Crossmark

Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH

Published Online: 2023-01-28

Authors

Marchianò, Silvia

Biagioli, Michele

Morretta, Elva

Di Giorgio, Cristina

Roselli, Rosalinda

Bordoni, Martina

Bellini, Rachele

Urbani, Ginevra

Massa, Carmen

Monti, Maria Chiara

Zampella, Angela

Distrutti, Eleonora

Fiorucci, Stefano
License Information

Text and Data Mining valid from 2023-01-28

Version of Record valid from 2023-01-28
More Information

Article History

Received: 25 October 2022

Accepted: 23 January 2023

First Online: 28 January 2023

Competing interests

: The authors declare no competing interests.

Document is current